-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Integer Holdings delivered Q1 2026 results that slightly beat expectations, with sales of $440M up 0.5% Y/Y, $14M above expectations. GAAP EPS improved to $0.48 vs. -$0.66 prior year, though adjusted EPS declined 8.4% to $1.20 and adjusted EBITDA fell 7%, reflecting underlying operational pressure. The most significant development was Integer's announcement of a strategic review process, in our view, with the Board exploring options including potential sale, merger, or strategic business combination. Management's risk-adjusted 2026 outlook with sales guidance of $1,805M-$1,835M implies a -3% to -1% Y/Y decline and adjusted EPS of $5.83-$6.40 (-9% to 0% Y/Y). Segment performance remained uneven, with CRM & Neuromodulation showing resilience at +5% Y/Y while C&V managed only 1% growth. In our view, the strategic review suggests the Board is evaluating whether standalone execution can deliver optimal shareholder value amid execution challenges.